{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:36:10Z","timestamp":1786977370616,"version":"build-2736575974"},"reference-count":20,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T00:00:00Z","timestamp":1432857600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cathet Cardio Intervent"],"published-print":{"date-parts":[[2015,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To determine event\u2010free survival after transcatheter closure of ventricular septal defect (VSD), and to identify predictors of adverse events (AE) in post myocardial infarction VSD (post\u2010MI VSD) subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>There are limited data on mid\u2010term follow\u2010up after transcatheter VSD closure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Retrospective review of 27 cases of transcatheter VSD closure (post\u2010MI\u2009=\u200918 and non\u2010ischemic\u2009=\u20099) performed from 1999 to 2013. We defined AE as death, device embolization, hemolysis requiring blood transfusion, heart block and reintervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In the post\u2010MI VSD subgroup, mean age and follow\u2010up was 69\u2009\u00b1\u200911 and 7.3\u2009\u00b1\u20097 years, respectively. AE occurred in 8 (44%) patients (death\u20103, device embolization\u20101, hemolysis\u20101, surgical VSD closure\u20102, reintervention\u20101). Event\u2010free survival was 56% at 1 month and 5 years, and all AE occurred in the periprocedural period. Cardiogenic shock (HR: 3.21, CI: 1.82\u20135.41,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.002), and VSD closure in acute phase (HR: 2.14, CI: 1.12\u20134.31,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.004) were independent predictors of AE. In the non\u2010ischemic VSD subgroup, mean age and follow\u2010up was 49\u2009\u00b1\u200915 and 8.7\u2009\u00b1\u20098 years, respectively. AE occurred in 3 (33%) patients (late death\u20101, surgical VSD closure\u20102). For the entire cohort, freedom from death was 89% and 85% at 1 month and 5 years, and event\u2010free survival was 70% and 61% at 1 month and 5 years.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Transcatheter closure of post\u2010MI VSD carries a moderate risk of periprocedural complications but low event rates afterwards. By comparison, device closure of non\u2010ischemic VSD has lower periprocedural morbidity but some patients continued to experience AE during follow\u2010up. \u00a9 2015 Wiley Periodicals, Inc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ccd.25989","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T15:40:58Z","timestamp":1432914058000},"page":"1264-1270","source":"Crossref","is-referenced-by-count":34,"title":["Transcatheter closure of postmyocardial infarction, iatrogenic, and postoperative ventricular septal defects: The Mayo Clinic experience"],"prefix":"10.1002","volume":"86","author":[{"given":"Alexander C.","family":"Egbe","sequence":"first","affiliation":[{"name":"Division of Cardiovascular Diseases Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Poterucha","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjit S.","family":"Rihal","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel W.","family":"Taggart","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Cetta","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison K.","family":"Cabalka","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Pollak","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy S.","family":"Reeder","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Diseases Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald J.","family":"Hagler","sequence":"additional","affiliation":[{"name":"Division of Pediatric Cardiology Mayo Clinic Rochester  Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,5,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.78.2.361"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-8703(99)70122-5"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(00)00482-6"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ccd.10784"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-0679(98)70005-X"},{"key":"e_1_2_7_7_1","first-page":"282","article-title":"Surgical treatment of postinfarction rupture of the interventricular septum. Texas heart institute journal\/from the Texas heart institute of St. Luke's Episcopal Hospital","volume":"18","author":"Calderon M","year":"1991","journal-title":"Texas Children's Hospital"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(84)80067-3"},{"key":"e_1_2_7_9_1","first-page":"138","article-title":"Early repair of postinfarction ventricular septal rupture","volume":"63","author":"Killen DA","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(99)00438-5"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)00878-0"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(03)00430-5"},{"key":"e_1_2_7_13_1","first-page":"491","article-title":"Percutaneous closure of postoperative and post\u2010traumatic ventricular septal defects","volume":"19","author":"Pedra CA","year":"2007","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_7_14_1","first-page":"402","article-title":"Transcatheter closure of postoperative residual ventricular septal defects using amplatzer\u2010type perimembranous VSD occluders","volume":"25","author":"Zhang B","year":"2013","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_7_15_1","first-page":"322","article-title":"Transcatheter closure of congenital and acquired muscular ventricular septal defects using the amplatzer device","volume":"14","author":"Chessa M","year":"2002","journal-title":"J Invasive Cardiol"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2005.09.068"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.10.047"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehn524"},{"key":"e_1_2_7_19_1","first-page":"43","article-title":"Primary transcatheter closure of postinfarction ventricular septal defects with the amplatzer septal occluder\u2010 immediate results and up\u2010to 5 years follow\u2010up","volume":"1","author":"Demkow M","year":"2005","journal-title":"EuroIntervention J EuroPCR Collaborat Working Group Intervent Cardiol Eur Soc Cardiol"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1043-0679(98)70006-1"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1010-7940(96)80371-X"}],"container-title":["Catheterization and Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fccd.25989","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccd.25989","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T19:46:28Z","timestamp":1696621588000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccd.25989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,29]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1002\/ccd.25989"],"URL":"https:\/\/doi.org\/10.1002\/ccd.25989","archive":["Portico"],"relation":{},"ISSN":["1522-1946","1522-726X"],"issn-type":[{"value":"1522-1946","type":"print"},{"value":"1522-726X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,29]]}}}